Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Phase II Study of MLN8237 (IND# 102984); a Selective Aurora A Kinase Inhibitor in Children with Recurrent/Refractory Solid Tumors and LeukemiasCIRB: Pediatric CIRBLead Group: COGStatus: CompletedReview Status: Completed
